PHARMAKINETICS LABORATORIES INC

Certification of termination of registration of a class of securities (Section 12(g))

Annual report pursuant to Section 13 or 15(d) (amendment)

5,7

General form for quarterly reports under Section 13 or 15(d)

5,7

5,7

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

5,7

5,7

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

5,7

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

5,7

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

5,7

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

5,7

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Definitive Proxy Statement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

5,7

Additional Information for Proxy Statement/ Votes

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

1,7

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

1,7

Post Effective Amendment to S-8

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Definitive Proxy Statement

Preliminary Proxy Statement

Current report pursuant to Section 13 or 15(d)

BIOANALYTICAL SYSTEMS INC